PACE-CME

How can GLP-1RA benefit a patient with diabetes and CKD?

How can GLPRA benefit a patient with diabetes and CKD
RestartResume
10' education - July 1, 2021 - Daniël van Raalte, MD, PhD - Online CME

Subtitles: English, French, German & more

  • Overview

    There is a need for therapies for patients with low eGFR. Daniël van Raalte discusses whether GLP-1RA therapy can provide benefit for patients with T2DM and CKD. With question to test your knowledge.

  • Educational information

    This lecture by Daniël van Raalte was part of the EBAC-accredited symposium "GLP-1RA in DKD: A new preventive challenge" held during the virtual ERA EDTA 2021 congress.

  • Faculty

    Dr. Daniël van Raalte is internist-endocrinologist in Amsterdam UMC, locatie VUmc, Amsterdam, The Netherlands.

  • Disclosures

    This recording was independently developed under auspices of PACE-cme. The views expressed in this recording are those of the individual presenter and do not necessarily reflect the views of PACE-cme.

  • Funding

    Funding for this educational program was provided by an unrestricted educational grant from Novo Nordisk A/S.

    The content is aimed for medical professionals. To view this item member registration is needed. Register for free to get unlimited access to our educational resources.

    Sorry, this content is unavailable in your country.

    The information and data provided in this program were updated and correct at the time of the program development, but may be subject to change.

Facebook Comments

Register

We’re glad to see you’re enjoying PACE-CME…
but how about a more personalized experience?

Register for free